$AMRZ

Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised

Amrize Ltd (AMRZ) reported Q2 2026 earnings call highlights citing strong revenue growth and raised guidance. Management said oil-driven cost inflation pressured margins, with adjusted EBITDA up 5.8% but lagging revenue. Cement pricing was slightly down 0.2% YoY in Q2, and full-year adjusted EBITDA guidance was revised to $3.1-$3.2 billion.

Original reporting
Published Aug 8, 2026, 3:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 3:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised — source image
Decision brief

The 30-second read

$AMRZBearishMed
01

Why it matters

Management guided to flat or low single-digit cement pricing in the full year but expects low single-digit pricing in the second half, while acknowledging price-over-cost remains negative through Q3 due to cost and pricing execution lags.

02

Market read

The key tradable update is the guidance reset to $3.1-$3.2B adjusted EBITDA and the stated timing of when price-over-cost turns positive (Q4), which directly affects 2026 earnings expectations.

03

What to watch

The call emphasizes lumpiness from insurance proceeds and land sales; traders may overfocus on operating margin without normalizing for these non-recurring items when comparing to prior periods.

Relevance 8/10Novelty 7/10Timing: ahead of/into the next trading session after the Q2 2026 earnings call

Background

The article summarizes Amrize’s Q2 2026 earnings call, focusing on revenue growth, margin pressure from oil-driven cost inflation, and revised full-year adjusted EBITDA guidance.

Company-level read

Ticker impact

$AMRZBearishMedium confidence
Context

Amrize raised and then revised full-year adjusted EBITDA guidance to $3.1-$3.2B, citing oil-driven cost inflation and cement pricing timing lags.

Expected impact

Near-term downside bias as traders reprice 2026 margins and the timing of price-cost normalization into Q4.

Evidence & confidence

The call discloses a specific guidance range reduction and explains why price-over-cost stays negative through Q3, which is typically a valuation and earnings-timing reset.

Market effects

Signals continued margin headwinds for building materials and building envelope players tied to freight and diesel costs, with price-cost timing lag as a key driver.

Highlights Canada strength in commercial categories (energy projects, data centers) and broad US pricing execution, which may influence regional demand/mix expectations.

Reinforces that geopolitical disturbances and oil-linked logistics costs are still flowing through to construction-materials earnings timing.

Counterpoint

If executed price increases continue to flow through faster than management’s 30-to-90 day lag assumptions, margins could stabilize earlier than the Q4 price-over-cost inflection implies.

Key entities

  • Amrize Ltd

    Subject of the earnings call highlights, including revised full-year adjusted EBITDA guidance and segment margin drivers.

  • Jan Jenisch

    Chairman and CEO discussing cement pricing execution, M&A cadence, and volume outlook.

  • Baris Oran

    CFO explaining guidance change drivers, including price-cost lag and fuel surcharge offsets.

Related articles

MedAI 8/10

Why is Amrize stock sliding today?

Amrize AG shares fell about 9.1% to around 38 after the company reported Q2 2026 results. EPS was $0.88 vs $0.96 expected, while revenue was $3.5B vs $3.35B expected. Amrize cut full-year adjusted EBITDA guidance, citing higher costs linked to elevated oil prices, driving the selloff.

$AMRZMedAI 8/10

Why is Amrize stock falling today?

Amrize AG shares fell 9.1% to CHF 38.02 after Q2 results missed expectations and the company cut its full-year adjusted EBITDA outlook, citing oil-price driven cost inflation. Q2 EPS was $0.88 vs $0.96 expected, while organic revenue rose 6.7% to $3.5B. Full-year revenue guidance was raised to $12.5B-$12.7B, but adjusted EBITDA was lowered to $3.1B-$3.2B.

$AMRZHighAI 9/10

Amrize Reports Second Quarter 2026 Results

Amrize (AMRZ) reported Q2 2026 revenues of $3,494 million, up 8.6% year over year, with net income rising 14.4% to $476 million and adjusted EBITDA up 5.8% to $986 million. The company returned $502 million via buybacks and dividends and raised FY 2026 guidance, citing demand and oil-price driven cost inflation. Capex was $241 million in the quarter.

$AMRZHigh

Amrize Ltd (AMRZ): Results of Operations and Financial Condition

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 amrizeq22026pressrelease.htm EX-99.1 amrizeq22026pressrelease Amrize Reports Second Quarter 2026 Results • Revenues up 8.6% with organic growth of 6.7% on strong demand and pricing • Net Income increased 14.4% to $476 million and Adjusted EBITDA grew 5.8% to $986 millio

$AMRZMed

Why is Amrize stock sliding today? By Investing.com

Investing.com reports Amrize AG shares fell 5.8% to $50.87 after Truist Securities analyst Keith Hughes downgraded the stock from Buy to Hold and cut the price target from $65 to $48. The target is below InvestingPro’s fair value ($56.69) and near the 52-week low ($44.12), following Q1 2026 earnings miss and segment volume softness.